Artículos con órdenes de acceso público - SABLONNIERE BernardMás información
No disponibles en ningún lugar: 2
Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats
CM Dhaenens, S Schraen-Maschke, H Tran, V Vingtdeux, D Ghanem, ...
Experimental neurology 210 (2), 467-478, 2008
Órdenes: US National Institutes of Health, National Institute of Health and Medical …
Slowly progressive spinocerebellar ataxia with extrapyramidal signs and mild cognitive impairment (SCA21)
J Delplanque, D Devos, I Vuillaume, A De Becdelievre, E Vangelder, ...
The Cerebellum 7, 179-183, 2008
Órdenes: National Institute of Health and Medical Research, France
Disponibles en algún lugar: 24
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
Órdenes: UK Medical Research Council, National Institute for Health Research, UK …
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
J Dumurgier, S Schraen, A Gabelle, O Vercruysse, S Bombois, ...
Alzheimer's research & therapy 7, 1-9, 2015
Órdenes: National Institute of Health and Medical Research, France
Tau as a biomarker of neurodegenerative diseases
S Schraen-Maschke, N Sergeant, CM Dhaenens, S Bombois, ...
Future Medicine Ltd 2 (4), 363-384, 2008
Órdenes: National Institute of Health and Medical Research, France
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease
G Grolez, C Moreau, B Sablonnière, G Garçon, JC Devedjian, S Meguig, ...
BMC neurology 15, 1-6, 2015
Órdenes: US National Institutes of Health
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
CM Dhaenens, S Burnouf, C Simonin, E Van Brussel, A Duhamel, ...
Neurobiology of disease 35 (3), 474-476, 2009
Órdenes: National Institute of Health and Medical Research, France
Association between caffeine intake and age at onset in Huntington's disease
C Simonin, C Duru, J Salleron, P Hincker, P Charles, A Delval, K Youssov, ...
Neurobiology of disease 58, 179-182, 2013
Órdenes: National Institute of Health and Medical Research, France
TMEM240 mutations cause spinocerebellar ataxia 21 with mental retardation and severe cognitive impairment
J Delplanque, D Devos, V Huin, A Genet, O Sand, C Moreau, C Goizet, ...
Brain 137 (10), 2657-2663, 2014
Órdenes: US National Institutes of Health, National Institute of Health and Medical …
Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing
CM Dhaenens, H Tran, ML Frandemiche, C Carpentier, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 732-742, 2011
Órdenes: National Institute of Health and Medical Research, France
RNF216 mutations as a novel cause of autosomal recessive Huntington-like disorder
P Santens, T Van Damme, W Steyaert, A Willaert, B Sablonnière, ...
Neurology 84 (17), 1760-1766, 2015
Órdenes: National Institute of Health and Medical Research, France
A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
S Lehmann, J Dumurgier, S Schraen, D Wallon, F Blanc, E Magnin, ...
Alzheimer's research & therapy 6, 1-9, 2014
Órdenes: National Institute of Health and Medical Research, France
Motor neuron pathology in CANVAS due to RFC1 expansions
V Huin, G Coarelli, C Guemy, S Boluda, R Debs, F Mochel, T Stojkovic, ...
Brain 145 (6), 2121-2132, 2022
Órdenes: UK Medical Research Council, Fondazione Cariplo, Agence Nationale de la …
N‐homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia
C Bossenmeyer‐Pourié, AD Smith, S Lehmann, V Deramecourt, ...
The Journal of Pathology 248 (3), 291-303, 2019
Órdenes: National Institute of Health and Medical Research, France
Clinical and genetic characteristics of late-onset Huntington's disease
M Oosterloo, EK Bijlsma, SM Van Kuijk, F Minkels, CEM de Die-Smulders
Parkinsonism & related disorders 61, 101-105, 2019
Órdenes: UK Medical Research Council, Wellcome Trust
MBNL1 gene variants as modifiers of disease severity in myotonic dystrophy type 1
V Huin, F Vasseur, S Schraen-Maschke, CM Dhaenens, P Devos, ...
Journal of neurology 260, 998-1003, 2013
Órdenes: National Institute of Health and Medical Research, France
Singular DYT6 phenotypes in association with new THAP1 frameshift mutations
A Blanchard, A Roubertie, M Simonetta‐Moreau, V Ea, C Coquart, ...
Movement disorders 26 (9), 1775-1776, 2011
Órdenes: National Institute of Health and Medical Research, France
RNA-binding disturbances as a continuum from spinocerebellar ataxia type 2 to Parkinson disease
A Nkiliza, E Mutez, C Simonin, F Leprêtre, A Duflot, M Figeac, C Villenet, ...
Neurobiology of disease 96, 312-322, 2016
Órdenes: National Institute of Health and Medical Research, France
Neglected comorbidity of chronic heart failure: iron deficiency
H Manceau, J Ausseil, D Masson, JP Feugeas, B Sablonniere, R Guieu, ...
Nutrients 14 (15), 3214, 2022
Órdenes: National Institute of Health and Medical Research, France, Agence Nationale …
Neurogenetics of the human adenosine receptor genes: Genetic structures and involvement in brain diseases
V Huin, CM Dhaenens, M Homa, K Carvalho, L Buée, B Sablonnière
Journal of Caffeine and Adenosine Research 9 (3), 73-88, 2019
Órdenes: National Institute of Health and Medical Research, France
La información de publicación y financiación se determina de forma automática mediante un programa informático